ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2130

Joint Manifestations in Patients Diagnosed with Idiopathic Inflammatory Myopathy: Multicenter Registry on Inflammatory Myositis from the Rheumatology Society in Madrid, Spain

Larissa Valor1, Diana Hernández-Flórez2, Julia Martínez-Barrio3, Beatriz E. Joven4, Laura Nuño5, Carmen Larena6, Irene Llorente7, Carmen Barbadillo8, Paloma Garcia De La Peña9, Lucía Ruíz Gutiérrez10, Henry Moruno Cruz11, Tatiana Cobo-Ibáñez12, Raquel Almodóvar González13, Leticia Lojo14, MARIA JESUS GARCIA DE YEBENES Y PROUS15 and Francisco Javier López Longo16, 1Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Rheumatology, Gregorio Marañón University General Hospital, Madrid, Spain, 3Servicio de Reumatologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 4Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 5Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Spain, 6Hospital Gregorio Marañón, Madrid, Spain, 7Rheumatology, H.U. La Princesa, Madrid, Spain, 8Hospital Universitario Puerta de Hierro, Madrid, Spain, 9Rheumatology, Hospital Madrid Norte Sanchinarro, Madrid, Spain, 10Pediatric Rheumathology Unit, University Children's Hospital Niño Jesús, Madrid, Spain, 11University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcalá de Henares, Madrid, Spain, 12Hospital Universitario Reina Sofía, Universidad Europea de Madrid, Madrid, Spain, 13Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, 14Rheumatology, Hospital Universitario La Paz, Spain, Spain, 15Institute for Musculoskeletal Health, Madrid, Spain, 16Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, dermatomyositis, myopathy and polymyositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Idiopathic inflammatory myopathies (IIM) comprise a heterogeneous group of autoimmune conditions characterized by muscle non-suppurative inflammation, progressive muscle weakness and a variety of extra-muscular manifestations. Joint involvement can be considered to be part of the IIM systemic manifestations, together with a possible gastrointestinal, cardiovascular and/ or pulmonary involvement. Although articular involvement in the IIM, including inflammatory arthralgia and arthritis, has been described as variable and non-specific with a chronic course it might be an early symptom of dermatomyositis in up to 30% of cases and in those patients with overlap syndromes. We aim to evaluate and to identify joint manifestations in IIM patients.

Methods: We evaluated a cohort of 479 patients that included 12 hospitals in the Community of Madrid belonging to the IIM registry of the Society of Rheumatology of Madrid (SORCOM-REMICAM) with diagnosis from January 1980 to December 2014. All patients were diagnosed of IIM according to Bohan and Peter criteria (Bohan A, Peter JB. N Engl J Med 1975 Feb 13;292(7):344-7). The presence of arthralgia and arthritis was considered. IIM were classified as dermatomyositis (primary and secondary dermatomyositis) (DM) and polymyositis (PM) including the rest of the patients (classification I). Also, IIM were classified (II) as primary polymyositis (PPM), primary dermatomyositis (PDM), overlap syndrome (OSd), juvenile myopathies (JM), cancer-associated myopathies (CAM), autoimmune necrotizing myopathy and inclusion body myositis (these were grouped as other myositis; OM).

Results: We found 70 (18%) patients with acute arthritis (<6 weeks), 74 (19%) patients with chronic arthritis (> 6 weeks) and 245 (65%) patients without any joint manifestations. Using the Tanimoto et al. criteria (1), the presence of erosive arthritis was observed in 149/479 (38.3%) of the patients. When comparing the joint manifestations in the PM and DM groups (n=250, 52.2% vs. n=229, 47.8%) no statistically significant differences were observed. However, assessing joint manifestations according to classification II, we observed that the highest prevalence was found in the OSd group, followed by the PDM group (p=0.0001). The group with less joint manifestations was JM compared to OSd and PDM (45% vs. 90% and 71%, respectively).

Conclusion: The presence of joint manifestations associated with IIM in our cohort is higher compared to other studies described in the literature so far and emphasize the importance of an accurate joint examination in these patients. The OSd group showed more joint manifestations which might be explained by the coexistence of SLE and MCTD patients in this group. Currently, no association between the clinical subtypes of IIM, overall, these results are encouraging and suggest that joint assessment in follow up may be helpful in differentiating subtypes of IIM.


Disclosure: L. Valor, None; D. Hernández-Flórez, None; J. Martínez-Barrio, None; B. E. Joven, None; L. Nuño, None; C. Larena, None; I. Llorente, None; C. Barbadillo, None; P. Garcia De La Peña, Fundación Española de Reumatología, 2; L. Ruíz Gutiérrez, None; H. Moruno Cruz, None; T. Cobo-Ibáñez, None; R. Almodóvar González, None; L. Lojo, None; M. J. GARCIA DE YEBENES Y PROUS, None; F. J. López Longo, None.

To cite this abstract in AMA style:

Valor L, Hernández-Flórez D, Martínez-Barrio J, Joven BE, Nuño L, Larena C, Llorente I, Barbadillo C, Garcia De La Peña P, Ruíz Gutiérrez L, Moruno Cruz H, Cobo-Ibáñez T, Almodóvar González R, Lojo L, GARCIA DE YEBENES Y PROUS MJ, López Longo FJ. Joint Manifestations in Patients Diagnosed with Idiopathic Inflammatory Myopathy: Multicenter Registry on Inflammatory Myositis from the Rheumatology Society in Madrid, Spain [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/joint-manifestations-in-patients-diagnosed-with-idiopathic-inflammatory-myopathy-multicenter-registry-on-inflammatory-myositis-from-the-rheumatology-society-in-madrid-spain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-manifestations-in-patients-diagnosed-with-idiopathic-inflammatory-myopathy-multicenter-registry-on-inflammatory-myositis-from-the-rheumatology-society-in-madrid-spain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology